http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-960021009-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 |
filingDate | 1994-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1996-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-960021009-A |
titleOfInvention | Omeprazole-containing composition for rectal administration |
abstract | The present invention is an omeprazole as an active ingredient; Water soluble basic amino acids as stabilizers; And a hydroxyl group composed of a mixture of fatty acid triglycerides and modal and diglycerides as a base contains an oil-soluble semisynthetic base of 10 or less. The composition for rectal administration according to the present invention provides excellent stability by using a water-soluble basic amino acid as a stabilizer and an oil-soluble semisynthetic base having a hydroxyl group of 10 or less, particularly preferably a hydroxyl group of 5 or less. |
priorityDate | 1994-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.